Cardovascular risk and Microparticles in GOLD Class A/B COPD?
Can Measuring CD31+EMPs predict loss of lung function, provide potential bio marker for accelerated lung function loss, and predict increased risk for atherosclerosis leading to increased risk for cardiovascular events?
Voting
4
net votes
8
up votes
4
down votes
Active
Idea No. 826